Increased Salivary Cytokines and Nitric Oxide Levels in Behçet's Disease: Interleukin-32, a Novel Player in Disease Prognosis.
Endocr Metab Immune Disord Drug Targets
; 23(3): 347-355, 2023.
Article
in En
| MEDLINE
| ID: mdl-35549879
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Behcet Syndrome
Type of study:
Prognostic_studies
Aspects:
Patient_preference
Limits:
Humans
Language:
En
Journal:
Endocr Metab Immune Disord Drug Targets
Year:
2023
Document type:
Article